Figure 1
From: Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome
Results of molecular analysis with Sanger sequencing according to the type of skin involvement. A presents the UBA1 mutation (p.Met41Leu, c.121A>C, mutational load >50%) observed with Sanger sequencing from a skin biopsy in a patient with VEXAS syndrome and neutrophilic dermatosis. B presents the UBA1-wild type gene observed in a skin biopsy in a patient with VEXAS syndrome and leukocytoclastic vasculitis